Company No:
Contents
| Note | 31.03.2026 | |
| £ | ||
| Fixed assets | ||
| Intangible assets | 3 |
|
| Tangible assets | 4 |
|
| 5,298 | ||
| Current assets | ||
| Cash at bank and in hand |
|
|
| 574 | ||
| Creditors: amounts falling due within one year | 5 | (
|
| Net current liabilities | (5,297) | |
| Total assets less current liabilities | 1 | |
| Net assets |
|
|
| Capital and reserves | ||
| Called-up share capital | 6 |
|
| Total shareholder's funds |
|
Director's responsibilities:
The financial statements of Entropyst Ltd (registered number:
|
Dr. A Badakhsh
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.
Entropyst Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is Inspire Hub 6th Floor, Graham Hills Building, 50 Richmond St, Glasgow, G1 1XU, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
The reporting period covers 15 months from incorporation on 8 January 2025 until the company's financial period end of 31 March 2026.
| Other intangible assets |
|
| Plant and machinery etc. |
|
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.
| Period from 08.01.2025 to 31.03.2026 |
|
| Number | |
| Monthly average number of persons employed by the Company during the period, including the director |
|
| Other intangible assets | Total | ||
| £ | £ | ||
| Cost | |||
| At 08 January 2025 |
|
|
|
| Additions |
|
|
|
| At 31 March 2026 |
|
|
|
| Accumulated amortisation | |||
| At 08 January 2025 |
|
|
|
| Charge for the financial period |
|
|
|
| At 31 March 2026 |
|
|
|
| Net book value | |||
| At 31 March 2026 |
|
|
| Plant and machinery etc. | Total | ||
| £ | £ | ||
| Cost | |||
| At 08 January 2025 |
|
|
|
| Additions |
|
|
|
| At 31 March 2026 |
|
|
|
| Accumulated depreciation | |||
| At 08 January 2025 |
|
|
|
| Charge for the financial period |
|
|
|
| At 31 March 2026 |
|
|
|
| Net book value | |||
| At 31 March 2026 | 862 | 862 |
| 31.03.2026 | |
| £ | |
| Other creditors |
|
| 31.03.2026 | |
| £ | |
| Allotted, called-up and fully-paid | |
|
|
|
Transactions with the entity's director
| 31.03.2026 | |
| £ | |
| Amounts owed to directors | 290 |
These amounts are unsecured, interest free and have no fixed repayment terms